264 related articles for article (PubMed ID: 27783105)
1. High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.
Veluchamy JP; Heeren AM; Spanholtz J; van Eendenburg JD; Heideman DA; Kenter GG; Verheul HM; van der Vliet HJ; Jordanova ES; de Gruijl TD
Cancer Immunol Immunother; 2017 Jan; 66(1):51-61. PubMed ID: 27783105
[TBL] [Abstract][Full Text] [Related]
2.
Veluchamy JP; Lopez-Lastra S; Spanholtz J; Bohme F; Kok N; Heideman DA; Verheul HM; Di Santo JP; de Gruijl TD; van der Vliet HJ
Front Immunol; 2017; 8():87. PubMed ID: 28220124
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy.
Lin SJ; Kuo ML
Pediatr Hematol Oncol; 2011 Nov; 28(8):640-6. PubMed ID: 21970456
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells differentiated in vitro from cord blood CD34
Domogala A; Blundell M; Thrasher A; Lowdell MW; Madrigal JA; Saudemont A
Cytotherapy; 2017 Jun; 19(6):710-720. PubMed ID: 28428057
[TBL] [Abstract][Full Text] [Related]
5. Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
Goldenson BH; Zhu H; Wang YM; Heragu N; Bernareggi D; Ruiz-Cisneros A; Bahena A; Ask EH; Hoel HJ; Malmberg KJ; Kaufman DS
Front Immunol; 2020; 11():561553. PubMed ID: 33178188
[TBL] [Abstract][Full Text] [Related]
6. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
[TBL] [Abstract][Full Text] [Related]
7. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
[TBL] [Abstract][Full Text] [Related]
8. Role of HLA-G and NCR in protection of umbilical cord blood haematopoietic stem cells from NK cell mediated cytotoxicity.
Wang M; Qiu Y; Wang X; Zhao F; Jin M; Xu M; Rong R; Ge H; Zhang Y; Wang X; Zhu T
J Cell Mol Med; 2011 Oct; 15(10):2040-5. PubMed ID: 21073654
[TBL] [Abstract][Full Text] [Related]
9. Impact of Graft-Versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood Transplantation.
Rettman P; Willem C; Volteau C; Legrand N; Chevallier P; Lodé L; Esbelin J; Cesbron A; Bonneville M; Moreau P; Senitzer D; Retière C; Gagne K
Transplantation; 2017 Sep; 101(9):2092-2101. PubMed ID: 27798515
[TBL] [Abstract][Full Text] [Related]
10. The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.
Verneris MR; Miller JS
Br J Haematol; 2009 Oct; 147(2):185-91. PubMed ID: 19796267
[TBL] [Abstract][Full Text] [Related]
11. Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells.
Luevano M; Domogala A; Blundell M; Jackson N; Pedroza-Pacheco I; Derniame S; Escobedo-Cousin M; Querol S; Thrasher A; Madrigal A; Saudemont A
PLoS One; 2014; 9(1):e87086. PubMed ID: 24489840
[TBL] [Abstract][Full Text] [Related]
12. Umbilical Cord Blood-Derived Natural Killer Cells Combined with Bevacizumab for Colorectal Cancer Treatment.
Xu C; Liu D; Chen Z; Zhuo F; Sun H; Hu J; Li T
Hum Gene Ther; 2019 Apr; 30(4):459-470. PubMed ID: 29914273
[TBL] [Abstract][Full Text] [Related]
13. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
[TBL] [Abstract][Full Text] [Related]
14. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro.
Noone C; Kihm A; English K; O'Dea S; Mahon BP
Stem Cells Dev; 2013 Nov; 22(22):3003-14. PubMed ID: 23795941
[TBL] [Abstract][Full Text] [Related]
16. Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer.
Zhao X; Cai L; Hu Y; Wang H
Front Immunol; 2020; 11():584099. PubMed ID: 33193399
[TBL] [Abstract][Full Text] [Related]
17. Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer.
Textor S; Dürst M; Jansen L; Accardi R; Tommasino M; Trunk MJ; Porgador A; Watzl C; Gissmann L; Cerwenka A
Int J Cancer; 2008 Nov; 123(10):2343-53. PubMed ID: 18712710
[TBL] [Abstract][Full Text] [Related]
18. HLA-C matching status does not affect rituximab-mediated antibody-dependent cellular cytotoxicity by allogeneic natural killer Cells.
Machino T; Okoshi Y; Miyake Y; Akatsuka Y; Chiba S
Immunol Invest; 2012; 41(8):831-46. PubMed ID: 22676066
[TBL] [Abstract][Full Text] [Related]
19. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
[TBL] [Abstract][Full Text] [Related]
20. Successful Transfer of Umbilical Cord Blood CD34
Dolstra H; Roeven MWH; Spanholtz J; Hangalapura BN; Tordoir M; Maas F; Leenders M; Bohme F; Kok N; Trilsbeek C; Paardekooper J; van der Waart AB; Westerweel PE; Snijders TJF; Cornelissen J; Bos G; Pruijt HFM; de Graaf AO; van der Reijden BA; Jansen JH; van der Meer A; Huls G; Cany J; Preijers F; Blijlevens NMA; Schaap NM
Clin Cancer Res; 2017 Aug; 23(15):4107-4118. PubMed ID: 28280089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
